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Infantile hemangiomas (IH) are the most common tumors of infancy. In the typical cutaneous presen-
tation, they follow a predictable and benign clinical course requiring medical intervention only for
growth that interferes with vision or respiration, or, rarely, in cases of intractable bleeding. Hemangi-
omas arising from within visceral structures or surfaces are far less common, but can be associated with
increased morbidity and mortality secondary to gastrointestinal hemorrhage, abdominal compartment
syndrome, high output cardiac failure, and hypothyroidism. Here we present the case of a three-week-
old boy with acute abdomen caused by hemorrhage of a hemangioma of the omentum and mesentery.
He underwent operative exploration with debulking of the lesion and was subsequently treated with
propranolol. Serial imaging demonstrated gradual involution and he remained free of further life-
threatening events.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Infantile hemangioma (IH) is themost common tumor of infancy
with an incidence between 1 and 9%, varying by race [1]. The mo-
lecular mechanisms underlying pathogenesis remain incompletely
understood, but the clinical course follows a stereotyped pattern: a
phase of early vascular proliferation over the ﬁrst year of life fol-
lowed by a gradual phase (1e7 years in duration) of spontaneous
involution and replacement of vascular channels by ﬁbro-fatty
tissue. Most cutaneous lesions follow a benign course. In the
absence of bleeding, ulceration, or impairment of vision or respi-
ration, treatment consists of observation and reassurance [2]. It has
been suggested that the presence of ﬁve or more cutaneous hem-
angiomas should arouse suspicion for the possibility of visceral
lesions [3], which are associated with higher rates of morbidity.
Visceral hemangiomas, most common in the liver, may be
associated with high output cardiac failure, coagulopathy, abdom-
inal compartment syndrome, or respiratory distress [4,5]. Cases of
small bowel perforation, intussusception, and gastrointestinal
hemorrhage from hemangiomatosis have been reported [6e8].BY-NC-ND license (http://
f Medicine, Department of
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Published by Elsevier Inc. All rightHere we describe a unique presentation of an omental and
mesenteric IH in a newborn boy, which hemorrhaged and caused an
inﬂammatory obstruction of the small bowel. After operative
exploration, lysis of adhesions, and partial debulking of the lesion,
post-operative treatment with propranolol was initiated and the
patient was followed with serial imaging. One year after initiation
of treatment, the hemangioma had largely regressed and he
remained symptom free.
1. Case report
A three-week-old boy born via emergent caesarian section (36
days, 6 weeks gestation) due to maternal HELLP syndrome and pre-
eclampsia, was noted shortly after birth to have multiple heman-
giomas on his lower lip, chin, and bilateral pre-auricular regions in
addition to one sublingual lesion. He was discharged homewithout
incident, but on day of life nineteen had decreased oral intake, ir-
ritability, and non-bilious emesis. He became febrile and lethargic
with a distended, ﬁrm abdomen and was admitted to the intensive
care with presumed sepsis. An abdominal x-ray demonstrated
dilated loops of small bowel and he had multiple heme-positive
small bowel movements. His infectious work-up remained negative
while his abdomen became increasingly ﬁrm and bowel move-
ments ceased. Laboratory values were signiﬁcant only for a nor-
mocytic anemia, with a hematocrit of 30.1%. Ultrasound
demonstrated a 4.3  1.9 cm complex collection in the uppers reserved.
Fig. 1. Abdominal ultrasound demonstrating 4.3  1.9 cm complex ﬂuid collectionwith
multiple, thick, internal septations and adjacent thickened loops of bowel.
Fig. 2. Immunohistochemistry showing GLUT-1 positivity (20).
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hyperemic loops of bowel, and a large amount of free ﬂuid with
echogenic debris (Fig. 1). No solid organ visceral hemangiomas
were appreciated.
Given a differential diagnosis that included visceral hemangioma,
macrocystic lymphatic malformation, and bowel perforation with
adjacent collection, the patient was taken for operative exploration.
Dark red-brown, clear, non-purulent ﬂuid was encountered upon
entering the abdomen. There was no evident bowel ischemia, but
there was an inﬂammatory process with a resultant band causing
obstruction of several loops of adjacent small bowel. Further dissec-
tion revealed a complex, beefy red, bosselated soft tissuemass arising
fromtheomentumbetween the greater curvature of the stomachand
transverse colon, extending laterally along the splenic ﬂexure and
inferiorly along the descending colon. This tissuewas dissected off of
the adjacent colonand resectedposteriorly to the retroperitoneumon
the anterior surface of the pancreas. It was felt that continuing the
dissection to include stripping the peritonealized surface of the
colonicandsmallbowelmesenteryaswell as thepancreasandsplenic
hilum was too risky and the decision was made to leave a small
amount of tissue abutting the pancreas, splenic hilumandmesenteric
pedicles to the colon and small bowel. There was a small (sub-
centimeter) hemangioma present on segment 2 of the liver, but no
evidence of diffuse hepatic involvement.
Pathology revealed an aggregate of irregular, pink-red, diffusely
hemorrhagic and necrotic soft tissues with well-formed capillary
spaces grouped in a lobular fashion, consistent with hemangioma.
The cells were subsequently shown to be positive for GLUT-1, but
not D2-40 further supporting the diagnosis of IH and making aFig. 3. a) T2 weighted, gadolinium enhanced MRI of the abdomen two months after initial p
splenic vein, celiac artery, SMA, and IVC. b) T2 weighted, non-contrast enhanced MRI six m
mesenteric hemangioma and a small decrease in the size of the retroperitoneal componencombined vascular-lymphatic malformation less likely (Fig. 2). The
patient was started on propranolol prior to discharge home. He was
readmitted one week later with abdominal distension, increased
fussiness, and difﬁculty sleeping. Ultrasound showed a large,
complex ﬂuid collection in the left abdomen and Interventional
Radiology placed a drain with successful resolution of the cavity.
Studies of the drain ﬂuid were not consistent with chylous ascites.
The patient remained on propranolol with surveillance MRI
performed two months after initial presentation revealing persis-
tent hemangioma along the root of the mesentery, encasing the
splenic vein, celiac artery, SMA, and IVC (Fig. 3a). Six months after
initial presentation, repeat MRI showed substantial decrease in the
size of the mesenteric hemangioma with slight decrease in the
extent of the retroperitoneal component (Fig. 3b). Clinically, he
continued to do well, meeting all developmental milestones with
appropriate weight gain. MRI one year after initial presentation
revealed near complete resolution of the lesion (Fig. 4).2. Discussion
This is an unusual case of visceral IH presenting not with
gastrointestinal bleeding, but rather as intra-abdominalresentation demonstrating hemangioma along the root of the mesentery, encasing the
onths after initial presentation demonstrating a signiﬁcant decrease in the amount of
ts.
Fig. 4. Repeat T2 weighted, contrast enhanced MRI 14 months after presentation
demonstrating near complete resolution of the hemangioma along all previously
involved surfaces.
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cases of infantile hemangioma treated with oral propranolol [9].
The treatment effect was suspected after a child taking propranolol
for cardiomyopathy demonstrated rapid involution of his nasal
hemangioma. Multiple, small, retrospective case series followed,
conﬁrming the effect and making propranolol a ﬁrst-line therapy
for IH, even in the absence of large, randomized, controlled trials
[10e12]. In 2011, the ﬁrst (albeit small) randomized, double-blin-
ded study demonstrated the superior effect of propranolol over
placebo, with a signiﬁcant reduction in volume, color, and elevation
of IH in the treatment group and no signiﬁcant side effects [13]. A
2013 meta-analysis pooled 35 studies to demonstrate propranolol’s
superior efﬁcacy over steroids, vincristine, and laser treatment
however only 6 of the 324 cases were visceral in origin (all hepatic)
[14]. Further literature search reveals reports of 15 hepatic lesions
successfully treated with propranolol [15e21].
Propranolol’s effect has been proposed to result from vasocon-
striction due to decreased nitric oxide release, down-regulation of
vascular growth factors, blocking of GLUT-1 receptors, and induction
of apoptosis [22]. The drug is well tolerated, exists in liquid prepara-
tion, and has a proven safety record with a long history of use in pe-
diatric cardiology. In the absence of large-scale clinical studies to
deﬁne evidence-based guidelines for its use in IH, a 2011 American
consensus conference reviewed the existing data and produced a set
of recommendations for propranolol dosing and monitoring [23].
Although its efﬁcacy has not been formally deﬁned in large-scale
randomized controlled trials, a growing body of evidence, including
this case of successful treatment of an omental andmesenteric lesion,
supports the use of propranolol in visceral infantile hemangiomas.
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